Iovance Biotherapeutics (IOVA) Prepaid Assets (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Prepaid Assets of $12.9 million for Q1 2026, down 18.68% year-over-year from $15.9 million in Q1 2025, and up 11.59% quarter-over-quarter from $11.6 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Prepaid Assets (2010 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Prepaid Assets for 17 consecutive years, with $12.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 18.68% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $12.9 million (down 18.68% YoY), while the FY2025 annual figure was $11.6 million, down 6.42% from the prior year.
- Prepaid Assets advanced to $12.9 million in Q1 2026 per IOVA's latest filing, from $11.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $17.5 million in Q4 2023 and bottomed at $7.1 million in Q2 2022.
- Historically, Prepaid Assets has averaged $11.5 million across 5 years, with a median of $11.5 million in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets sank 31.09% — and 2023, when it surged 140.1%.
- Iovance Biotherapeutics' Prepaid Assets stood at $7.3 million in 2022, then jumped by 140.1% to $17.5 million in 2023, then dropped by 29.1% to $12.4 million in 2024, then decreased by 6.42% to $11.6 million in 2025, then gained by 11.59% to $12.9 million in 2026.
- Business Quant data shows IOVA's Prepaid Assets at $12.9 million in Q1 2026, $11.6 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.87 Mn |
| Mar 31, 2026 | 12.93 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 15.89 Mn |
| Dec 31, 2024 | 12.38 Mn |
| Mar 31, 2024 | 11.49 Mn |
| Dec 31, 2023 | 17.46 Mn |
| Sep 30, 2023 | 12.02 Mn |
| Jun 30, 2023 | 14.23 Mn |
| Mar 31, 2023 | 11.49 Mn |
| Dec 31, 2022 | 7.27 Mn |
| Sep 30, 2022 | 9.71 Mn |
| Jun 30, 2022 | 7.14 Mn |
| Mar 31, 2022 | 7.78 Mn |
| Dec 31, 2021 | 3.55 Mn |
| Sep 30, 2021 | 6.58 Mn |
| Jun 30, 2021 | 10.27 Mn |
| Mar 31, 2021 | 11.29 Mn |